We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRDN icon
326
Viridian Therapeutics
VRDN
$2.59B
– –
-81,870
Closed -$1.68M
VRNA
327
DELISTED
Verona Pharma
VRNA
– –
-111,926
Closed -$1.14M
VSTM icon
328
Verastem
VSTM
$543M
– –
-74,095
Closed -$756K
VTR icon
329
Ventas
VTR
$47.6B
– –
-88,499
Closed -$3.56M
VTYX
330
DELISTED
Ventyx Biosciences
VTYX
– –
-29,400
Closed -$1.03M
W icon
331
Wayfair
W
$14.9B
– –
-29,500
Closed -$960K
WCN
332
Waste Connections
WCN
$42.5B
– –
-18,200
Closed -$2.46M
WELL icon
333
Welltower
WELL
$171B
– –
-238,217
Closed -$15.3M
WEN icon
334
Wendy's
WEN
$1.43B
– –
-429,000
Closed -$8.02M
WH icon
335
Wyndham Hotels & Resorts
WH
$5.53B
– –
-174,226
Closed -$10.7M
WM icon
336
Waste Management
WM
$92.4B
– –
-35,201
Closed -$5.64M
WTI icon
337
PUT
W&T Offshore
WTI
$510M
– –
-1,580,400
Closed -$95K
WYNN icon
338
PUT
Wynn Resorts
WYNN
$10.5B
– –
-7,000
Closed -$342K
XBI icon
339
State Street SPDR S&P Biotech ETF
XBI
$10.2B
– –
-50,000
Closed -$3.97M
XENE icon
340
Xenon Pharmaceuticals
XENE
$6.13B
– –
-54,208
Closed -$1.96M
XLF icon
341
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
– –
-1,200,000
Closed -$2.21M
XOM icon
342
ExxonMobil
XOM
$633B
– –
-9,500
Closed -$829K
XRX icon
343
PUT
Xerox
XRX
$427M
– –
-42,700
Closed -$363K
XYL icon
344
Xylem
XYL
$28.5B
– –
-6,155
Closed -$538K
YMAB
345
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-44,000
Closed -$634K
ZCAR
346
DELISTED
Zoomcar
ZCAR
– –
-191
Closed -$3.87M
ZLAB icon
347
Zai Lab
ZLAB
$2.59B
– –
-15,700
Closed -$537K
ZNTL icon
348
Zentalis Pharmaceuticals
ZNTL
$299M
– –
-13,527
Closed -$293K
ZTO icon
349
ZTO Express
ZTO
$17.8B
– –
-152,240
Closed -$3.66M
ZURA icon
350
Zura Bio
ZURA
$551M
– –
-238,623
Closed -$2.4M
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.